414 related articles for article (PubMed ID: 38051891)
1. Targeting tau in Alzheimer's disease: from mechanisms to clinical therapy.
Ye J; Wan H; Chen S; Liu GP
Neural Regen Res; 2024 Jul; 19(7):1489-1498. PubMed ID: 38051891
[TBL] [Abstract][Full Text] [Related]
2. Toxic tau: structural origins of tau aggregation in Alzheimer's disease.
Mamun AA; Uddin MS; Mathew B; Ashraf GM
Neural Regen Res; 2020 Aug; 15(8):1417-1420. PubMed ID: 31997800
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
Iqbal K; Grundke-Iqbal I
Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Tau Pathology in Alzheimer's Disease by Dietary Bioactive Compounds.
Shi H; Zhao Y
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255905
[TBL] [Abstract][Full Text] [Related]
5. Tau truncation in the pathogenesis of Alzheimer's disease: a narrative review.
Chu D; Yang X; Wang J; Zhou Y; Gu JH; Miao J; Wu F; Liu F
Neural Regen Res; 2024 Jun; 19(6):1221-1232. PubMed ID: 37905868
[TBL] [Abstract][Full Text] [Related]
6. A three-dimensional human neural cell culture model of Alzheimer's disease.
Choi SH; Kim YH; Hebisch M; Sliwinski C; Lee S; D'Avanzo C; Chen H; Hooli B; Asselin C; Muffat J; Klee JB; Zhang C; Wainger BJ; Peitz M; Kovacs DM; Woolf CJ; Wagner SL; Tanzi RE; Kim DY
Nature; 2014 Nov; 515(7526):274-8. PubMed ID: 25307057
[TBL] [Abstract][Full Text] [Related]
7. Disrupted ubiquitin proteasome system underlying tau accumulation in Alzheimer's disease.
Weng FL; He L
Neurobiol Aging; 2021 Mar; 99():79-85. PubMed ID: 33422896
[TBL] [Abstract][Full Text] [Related]
8. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
[TBL] [Abstract][Full Text] [Related]
9. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
[TBL] [Abstract][Full Text] [Related]
10. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
11. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease.
Roda AR; Serra-Mir G; Montoliu-Gaya L; Tiessler L; Villegas S
Neural Regen Res; 2022 Aug; 17(8):1666-1674. PubMed ID: 35017413
[TBL] [Abstract][Full Text] [Related]
13. SUMO and Alzheimer's disease.
Lee L; Sakurai M; Matsuzaki S; Arancio O; Fraser P
Neuromolecular Med; 2013 Dec; 15(4):720-36. PubMed ID: 23979993
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's pathology targets distinct memory networks in the ageing brain.
Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ
Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481
[TBL] [Abstract][Full Text] [Related]
15. Tauopathy: A common mechanism for neurodegeneration and brain aging.
Saha P; Sen N
Mech Ageing Dev; 2019 Mar; 178():72-79. PubMed ID: 30668956
[TBL] [Abstract][Full Text] [Related]
16. SUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease?
Hoppe JB; Salbego CG; Cimarosti H
Aging Dis; 2015 Sep; 6(5):322-30. PubMed ID: 26425387
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
[TBL] [Abstract][Full Text] [Related]
18. Relationship between tau pathology and neuroinflammation in Alzheimer's disease.
Metcalfe MJ; Figueiredo-Pereira ME
Mt Sinai J Med; 2010; 77(1):50-8. PubMed ID: 20101714
[TBL] [Abstract][Full Text] [Related]
19. The complexity of tau in Alzheimer's disease.
Naseri NN; Wang H; Guo J; Sharma M; Luo W
Neurosci Lett; 2019 Jul; 705():183-194. PubMed ID: 31028844
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylated tau targeted small-molecule PROTACs for the treatment of Alzheimer's disease and tauopathies.
Jangampalli Adi P; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2021 Aug; 1867(8):166162. PubMed ID: 33940164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
